Pancreatic Cancer Research

ResearcherCarol Davila University of Medicine and PharmacyActive in the last 2 years

Simona Dima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5275-8938; OpenAlex author ID A5026937938. Sources: OpenAlex.

Their work

Papers
18 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 3 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 18

  1. The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review. Last author DOI 10.3389/fphar.2026.1815366↗
  2. Unexpected Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma Harboring KRAS G12R with an Ultra-Low-VAF SMAD4 Mutation: A Case Report and Mini-Rev… Co-author DOI 10.3390/reports9030285↗
  3. Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective… Co-author DOI 10.3390/ijms25052854↗
  4. Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis. Co-author DOI 10.3748/wjg.v29.i18.2864↗
  5. Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease. Co-author DOI 10.21614/chirurgia.2772↗
  6. The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma. Last author DOI 10.3390/ijms23169045↗
  7. Functional expression of the transient receptor potential ankyrin type 1 channel in pancreatic adenocarcinoma cells. Co-author DOI 10.1038/s41598-021-81250-3↗
  8. Publisher Correction: Functional expression of the transient receptor potential ankyrin type 1 channel in pancreatic adenocarcinoma cells. Co-author DOI 10.1038/s41598-021-88169-9↗
  9. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2020/6148286↗
  10. Pancreatoduodenectomy After Neoadjuvant Chemotherapy for Locally Advanced Pancreatic Cancer in the Presence of an Aberrant Right Hepatic Artery. Co-author DOI 10.21873/invivo.11788↗
  11. Morphometric Assessment of Confocal Laser Endomicroscopy for Pancreatic Ductal Adenocarcinoma, an Ex-Vivo Pilot Study. Co-author DOI 10.3390/diagnostics10110923↗
  12. Pancreatoduodenectomy En Bloc With Vascular Resections in Borderline Resectable Pancreatic Cancer. Co-author DOI 10.21873/invivo.11738↗
  13. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma. Co-author DOI 10.21614/chirurgia.113.3.363↗
  14. Epigenetic Silencing of GNMT Gene in Pancreatic Adenocarcinoma. Co-author PMID 25560641↗
  15. Impact of Hepatitis B Virus on Clinicopathological Features and Outcomes After Resection for Pancreatic Adenocarcinoma. Co-author PMID 26254417↗
  16. Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1097/mpa.0000000000000106↗
  17. An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e3182546e13↗
  18. Update in pancreatic cancer surgery - focus on total mesopancreas excision. First author PMID 23118831↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Irinel Popescu · 13 shared papers, 2012–2024 · strength 1.38
  2. Bianca Varzaru · 3 shared papers, 2023–2026 · strength 0.66
  3. Cristian Gheorghe · 3 shared papers, 2023–2026 · strength 0.66
  4. Traian Dumitraşcu · 6 shared papers, 2012–2022 · strength 0.54
  5. Vladislav Braşoveanu · 5 shared papers, 2015–2020 · strength 0.46
  6. Dana Cucu · 4 shared papers, 2014–2022 · strength 0.46
  7. Alexandru-Ioan Pintea · 1 shared paper, 2026 · strength 0.43
  8. Florentina Cojocaru · 3 shared papers, 2021–2022 · strength 0.41
  9. Nicoleta-Raluca Chelaru · 3 shared papers, 2021–2022 · strength 0.41
  10. Dan Gabriel Duda · 4 shared papers, 2012–2022 · strength 0.35
  11. Ștefania Bunduc · 2 shared papers, 2023–2024 · strength 0.35
  12. Ioana Gabriela Lupescu · 1 shared paper, 2026 · strength 0.32
  13. Nicolae Bacalbașa · 3 shared papers, 2015–2020 · strength 0.28
  14. Iulian Brezean · 2 shared papers, 2019–2020 · strength 0.23
  15. Irina Bălescu · 2 shared papers, 2019–2020 · strength 0.23
  16. Vlad Herlea · 3 shared papers, 2012–2020 · strength 0.18
  17. Bogdan Silviu Ungureanu · 1 shared paper, 2020 · strength 0.13
  18. Valeriu Şurlin · 1 shared paper, 2020 · strength 0.13
  19. Adrian Săftoiu · 1 shared paper, 2020 · strength 0.13
  20. Cătălin Vasilescu · 1 shared paper, 2020 · strength 0.10
  21. Anca Botezatu · 1 shared paper, 2015 · strength 0.05
  22. Pascal Pineau · 1 shared paper, 2015 · strength 0.05
  23. Akira Horii · 1 shared paper, 2014 · strength 0.04
  24. Cristiana Tănase · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.